A modified melanoma-molGPA scoring model: assessment of survival after and efficacy of different radiotherapy modalities in patients with melanoma brain metastases

PURPOSE: Patients with malignant melanoma brain metastases (MBMs) have poor prognoses. For MBMs, the Melanoma-molGPA is the most widely used predictive score, but its predictive value remains uncertain in patients fully treated with radiotherapy. We identified MBMs prognostic factors and modified th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qian, Zhang, Xueqing, Li, Hui, Tang, Lirui, Zeng, Yibin, Lin, Jing, Chen, Yu, Li, Jinluan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310639/
https://www.ncbi.nlm.nih.gov/pubmed/37382755
http://dx.doi.org/10.1007/s12672-023-00722-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310639/
https://www.ncbi.nlm.nih.gov/pubmed/37382755
http://dx.doi.org/10.1007/s12672-023-00722-2

Ejemplares similares